Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy.
2021
REPLY: Dr. Wee and colleagues reviewed their database of gastroenteropancreatic neuroendocrine tumor patients treated with 177Lu-DOTATATE and observed patterns of bowel obstruction very similar to those described in our study ( [1][1] ). These corroborating data significantly strengthen the evidence
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI